is an extremely potent environmental contaminant that produces a wide range of adverse biological effects, including the induction of cytochrome P450 1A1(CYP1A1) that may enhance the toxic effects of TCDD. Several studies indicated that concurrent supplementation of vitamin A could reduce the toxicity, and potentially inhibit CYP1A1 activity (measured as EROD activity). In the present study, we investigated the in vivo effects of vitamin A on EROD activities and the expression of CYP1A1 in the liver of TCDD-treated mice. In Experiment , the mice were given a single oral dose of 40 µg TCDD/kg body weight with or without the continuous administration of 2500IU vitamin A/kg body weight/day, and were killed on day 1, 3, 7, 14 or 28. In Experiment , the mice were given Cytochrome P450s belong to the superfamily of enzymes that are involved in the metabolism of many endogenous and exogenous compounds, such as steroid hormones, drugs, and environmental pollutants (Honkakoski and Negishi, 2000) . These enzymes can be modulated by endogenous and exogenous factors (Nelson et al., 1996) , and in turn, they may influence the biological actions of the environmental compounds. Therefore, the effects of natural and synthetic compounds on cytochrome P450 enzymes have attracted considerable interest.
Cytochrome P450s belong to the superfamily of enzymes that are involved in the metabolism of many endogenous and exogenous compounds, such as steroid hormones, drugs, and environmental pollutants (Honkakoski and Negishi, 2000) . These enzymes can be modulated by endogenous and exogenous factors (Nelson et al., 1996) , and in turn, they may influence the biological actions of the environmental compounds. Therefore, the effects of natural and synthetic compounds on cytochrome P450 enzymes have attracted considerable interest.
Cytochrome P4501A1 (CYP1A1) is of major interest for its bioactivation of many procarcinogens including benzo (a) pyrene (B (a) P) (Whitlock, 1999; Shou et al., 1994) . Its most potent known inducer is 2,3,7,8-tetrachlorodi -benzo-p-dioxin (TCDD).
TCDD is a ubiquitous environmental contaminant, which induces a variety of toxic responses via binding and activating the aryl hydrocarbon receptor (AhR). The TCDD-AhR complex forms a heterodimer with the AhR nuclear translocator (ARNT) and the TCDD-AhR-ARNT complex then binds to specific sequences in the DNA called Dioxin Responsive Elements (DRE) and alters the expression of a wide variety of genes, including CYP1A1 (Schmidt and Bradfield, 1996) . Vitamin A (retinol) is an essential micronutrient that plays a central role in various physiological processes, such as reproduction, cell growth and differentiation, immunity, embryogenesis and vision (Chambon, 1994; Maden et al., 1998) . It exerts its effects by conversion to the biologically active derivatives, retinal and retinoic acid (RA) (Chambon, 1996) . With the exception of vision, RA fulfills the majority of vitamin A actions via binding and activating two families of ligand-activated nuclear retinoid receptors, retinoic acid receptor (RAR) and retinoid X Ltd (Shanghai, China). AMV Reverse Transcription System (A3500) was purchased from Promega (USA). Taq DNA polymerase and dNTP were purchased from MBI Fermentas (Lithuania). All the primers were designed using Primer Express Software v2.0 (Applied Biosystems, Foster City, CA, USA) and synthesized by the Shanghai Sangon Biological Engineering Company, China. Other chemicals and solvents were of analytical grade or HPLC grade.
Animals. Four-week-old male C57BL6 mice were obtained from Beijing Vital River Laboratory Animal Co, Ltd (Beijing, China). They were housed in plastic cages containing sawdust bedding in groups of five. The animals were kept at room temperature of 22±2 and fed standard rodent chow and water ad libitum. The feed, in which the vitamin A content was 11,000IU/kg, was obtained from Laboratory Animal Center, Shantou University Medical College.
Treatment schedule. In this study, single and repeated TCDD exposures were designed. Histological examination. Tissue samples were preserved in 10% neutral buffered formalin, embedded in paraffin wax and cut to the thickness of 4 µm. The tissue sections were stained with hematoxylin and eosin (HE), and examined using light microscope independently by two pathologists. The degree of hepatoxicity was graded on a scale of 1 to 5, as categorized by
Smith et al. (1998).
Hepatic CYP1A1 activity. The hepatic microsomal fraction was isolated by differential centrifugation at 10,000 g for 20 min, followed by a centrifugation at 105,000 g for 1 h at 4 (Wei et al., 1995) . The resulting microsomal pellet was suspended in 0.1mol/L phosphatebuffered solution and stored in aliquots at -70 . The protein content of the microsomes was measured by the Bradford method, using bovine serum albumin as the reference (Bradford, 1976) .
Hepatic CYP1A1 activity was measured using ethoxyresorufin-O-deethylase (EROD) assay. Master SYBR Green I mix, 150nmol/L gene-specific forward and reverse primers and 1.5 units Taq DNA polymerase. The thermal cycling conditions comprised an initial denaturation step at 95°C for 5 min, 40 cycles at 95°C for 15 s, 60°C for 30s and 72°C for 30s. Consequently, at the end of the PCR cycles, the real-time PCR products were immediately analyzed using a ramping rate of 0.03°C/s from 60 to 95°C to calculate the dissociation curve to confirm that single PCR product was detected by SYBR Green I dye. No-template control reactions for every primer pair were also included on each reaction plate to check for external DNA contamination.
Sequence-specific standard curves were generated using 10-fold serial dilutions of plasmid DNA, and then the value for the initial concentration of unknown samples was calculated by the software (version1.7) provided with the ABI 7700 system. Samples were normalized using the housekeeping gene -actin. Each measurement of sample was conducted in duplicate.
Western Blotting. Microsomal proteins (15µg/lane) were resolved using 10% Sodium dodecy1 sulfate-gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane (Hybond P, Amersham, UK). The primary antibody was the rabbit polyclonal anti CYP1A1
antibody (Santa Cruz, USA). The secondary antibody was alkaline phosphatase-linked goat anti-rabbit IgG (Promega, USA). The positive bands representing CYP1A1 protein were developed using the Western Blue Stabilized Substrate for Alkaline Phosphatase (Promega, USA).
Statistical Analysis. All values were expressed as arithmetic means ± standard deviation.
Group means for relative liver weights, EROD activity, and the mRNA expression of CYP1A1, AhR and ARNT were evaluated using One-way analysis of variance (ANOVA). If the data were homogenous and normally distributed, multiple comparisons were made by Newman-Keuls test. If tests for normality or variance failed, the Kruskal-Wallis one-way ANOVA on ranks was carried out and followed with the Nemenyi test for multiple comparisons.
P<0.05 was considered as statistically significant.
RESULT

General toxicity
No mice died during the study period. There was no significant difference in animal body weight between the four groups at each testing point in both experiments (data not shown).
Hepatic toxicity
In Experiment (table 2) , the relative liver weights in TCDD-treated (40 g /kg) mice began to increase as early as 1 day, peaked after 3 days and remained high till 28 days after TCDD exposure. Supplement of Vitamin A (2500IU/kg) showed neither significant effect on the relative liver weights during the experiment, nor significant influence on the increase of relative liver weights induced by single TCDD dose.
In Experiment (table 3) Either single or repeated exposures to TCDD caused liver damage with hepatocyte hydropic changes, necrosis, and inflammatory cell infiltration (Fig 1) . In single exposed mice, the liver damage aggravated with time, reached the most severe after 14 days, and began to ameliorate after 28 days; in repeated exposed mice, the liver damage showed an aggravating tendency, and reached its peak after 42 days. In mice treated with TCDD+vitamin A, the liver damage was less severe than that in TCDD-treated mice in both experiments (Table2 and 3).
Hepatic EROD activity
In both experiments, TCDD induced high hepatic EROD activity, while supplement of vitamin A had no apparent effect. In Experiment I, the EROD activity began to increase as early as 1 day following single exposure to TCDD, peaked after 3 days and remained high until 28 days. The EROD activity increased in TCDD-treated mice by 42-fold over the control mice at 7 days. In Experiment II, repeated TCDD treatment increased EROD activity with time and reached a 44-fold over the control mice at 42 days. In both experiments, the EROD activity in TCDD+vitamin A-treated mice was lower than that in the TCDD-treated mice. The EROD activities in TCDD+vitamin A-treated mice was 17% lower after 7 days following single exposure to TCDD and 28% lower (P<0.05) after 42 days repeated treatment of TCDD, compared with the TCDD-treated mice respectively (Fig 2) .
Hepatic CYP1A1 mRNA expression
Mice liver CYP1A1 mRNA expression was quantified by Real-Time PCR (Fig 3) . TCDD significantly increased the expression of liver CYP1A1 mRNA in both experiments, however, supplement of vitamin A showed no obvious effects on it. In Experiment I, CYP1A1 mRNA expression began to increase as early as 1 day following single exposure to TCDD, peaked after 7 days and remained high until 28 days. CYP1A1 mRNA expression increased by 97-fold in TCDD-treated mice over the control mice at 7 days. In Experiment II, repeated TCDD treatment increased CYP1A1 mRNA expression with time and approached to 47-fold over the control mice at 42 days. In both experiments, the CYP1A1 mRNA expression in TCDD+vitamin A-treated mice was lower than that in the TCDD-treated mice. The magnitude of CYP1A1 mRNA expression in TCDD+vitamin A-treated mice was 25% lower after 3 days following single exposure to TCDD and 68% lower (P<0.05) after 42 days of repeated treatment with TCDD, compared with the TCDD-treated mice respectively.
Hepatic CYP1A1 protein expression
Hepatic CYP1A1 protein expression was detected by western blotting (Fig 4) . CYP1A1
protein was not detectable in the livers treated with vehicle (control) or vitamin A at each checking time. The magnitude of positive bands in TCDD-treated mice was significantly higher than that in the mice treated with TCDD+vitamin A. CYP1A1 protein levels increased and peaked at the time of 7 or 42 days after TCDD dosing in two experiments respectively, whilst supplementation of vitamin A reduced such increase.
Hepatic AhR mRNA expression
AhR mRNA expression in mice livers was quantified by Real-Time PCR (Fig 5) . TCDD significantly increased the expression of AhR mRNA in both experiments; however, supplement of vitamin A did not affect it at each checking time. In Experiment I, hepatic AhR mRNA expression began to increase as early as 1 day following single exposure to TCDD, peaked after 7 days and remained high until 28 days. The magnitude of AhR mRNA expression was increased by 4.5-fold in TCDD-treated mice over the control mice after 7 days. In Experiment II, TCDD increased AhR mRNA expression with time and approached to a 3.3-fold over the control mice after 42 days. In both experiments, the AhR mRNA expression in TCDD+vitamin A-treated mice was lower than that in the TCDD-treated mice. The magnitude of AhR mRNA expression in TCDD+vitamin A-treated mice was 52.6% lower (P<0.05) after 3 days following single exposure to TCDD and 43.8% lower (P<0.05) after 28 days repeated treatment of TCDD, compared with the TCDD-treated mice respectively.
Hepatic ARNT mRNA expression
Liver ARNT mRNA expression in mice was quantified by Real-Time PCR (Fig 6) . Though TCDD increased the expression of ARNT mRNA, the differences were not significant compared with the control mice. Vitamin A did not affect the expression of ARNT mRNA during the test.
DISCUSSION
Exposure to TCDD results in various adverse biological effects in experimental animals, such as hepatic damage, thymic atrophy and immune dysfunction, and several types of cancer (Pohjanvirta and Tuomisto, 1994) . Changed vitamin A homeostasis may be related to some TCDD-induced toxicity, such as the wasting syndrome (Fletcher et al., 2001; Zile, 1992) . Stohs et al. (1984) found that vitamin A abolished the hepatic lipid peroxidation caused by TCDD, but exhibited little influence on the lethality induced by TCDD. In this study, we found that both a single oral dose of 40µg/kg or repeated dose of 0.1µg/kg TCDD significantly increased the relative liver weight and caused liver damage, and that the liver damage in TCDD+vitamin A-treated mice was less severe than that in the TCDD-treated mice, which demonstrates that supplementation of vitamin A attenuates the liver damage caused by TCDD.
TCDD induce CYP1A1 activity and gene expression in various tissues (Charles and
Shiverick, 1997; Kress and Greenlee, 1997) . Increased CYP1A1 expression may contribute towards some toxic effects of TCDD (Nebert, 1991) . Both CYP1A1 mRNA and protein are virtually undetectable in untreated animals or cells, but following exposure to TCDD, can be among the most abundant in the cell (Nebert, 1989) . Experiments showed that antisense blockade of CYP1A synthesis in developing fish embryos attenuated TCDD-induced developmental toxicity, supporting the idea that CYP1A family member's gene expression contributes to TCDD-induced toxicity (Teraoka et al., 2003) . Uno et al. (2004) Transcriptional activation of CYP1A1 induced by TCDD is mediated via AhR, a cytosolic protein that belongs to the basic helix-loop-helix protein family. Upon ligand binding, AhR translocates to the nucleus where it binds to a nuclear transcription factor, ARNT. Heterodimer of AhR and ARNT binds to consensus sequences in the regulatory domains of the CYP1A1 gene and stimulates its transcription (Hankinson, 1995; Schmidt and Bradfield, 1996) . Huang et al (2003) reported that single oral dose of 50 g /kg TCDD increased AhR mRNA expression significantly, 7 days after dosing, but did not alter the ARNT mRNA expression in mouse liver. In this study, we also found that both a single oral dose of 40µg/kg or repeated exposure of 0.1µg/kg TCDD, increased the expression of AhR mRNA, but did not affect the expression of ARNT mRNA in mouse liver. Moreover, the time course of CYP1A1 mRNA and AhR mRNA were similar. Wanner et al. (1996) observed that all-trans-RA, as the biologically active form of vitamin A, could decrease the expression of the AhR and ARNT in proliferative keratinocytes. In our study, Most of vitamin A functions are mediated through the binding of its active metabolite, RA, to nuclear receptors (Chambon, 1996) . Although TCDD could increase the all-trans-RA contents in rats (Schmidt, 2003) , TCDD prevents some gene expression regulated by retinoic acid (Krig, et al., 2002) . Moreover, Inouye et al. (1999) pointed out that the inhibitory ability of all-trans retinoic acid on CYP1A1-dependent 7-ethoxycoumarin deethylation is not so strong as that of all-trans-retinol. In this 
